PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsCalcium dobesilate
Calcium dobesilate
Calcium dobesilate is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
e l f camo semi matte cc spf 30 light 205 nC2002632025-10-31
e.l.f. camo cc cream spf 30 deep 500 w e.l.f. camo cc cream spf 30 deep 510 c e.l.f. camo cc cream spf 30 deep 530 w e.l.f. camo cc cream spf 30 de...C2002632025-09-18
e.l.f. hydrating camo cc cream spf30 deep 500 w e.l.f. hydrating camo cc cream spf30 deep 510 w e.l.f. hydrating camo cc cream spf30 deep 530 n e.l...C2002632025-09-17
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
C: Cardiovascular system drugs
— C05: Vasoprotectives
— C05B: Antivaricose therapy drugs
— C05BX: Other sclerosing agents in atc
— C05BX01: Calcium dobesilate
— C05BX51: Calcium dobesilate, combinations
HCPCS
No data
Clinical
Clinical Trials
1106 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Multiple myelomaD009101—C90.01081843837284
Precursor cell lymphoblastic leukemia-lymphomaD054198—C91.030542724103
Macular edemaD008269——21814293494
Plasma cell neoplasmsD054219——3460132388
LeukemiaD007938—C952138141367
LymphomaD008223—C85.9153381252
Postoperative painD010149—G89.1824721839
Lymphoid leukemiaD007945—C91142181—38
RecurrenceD012008——162151—34
CataractD002386EFO_0001059H26.9—2718734
Show 179 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-hodgkin lymphomaD008228—C85.99183—230
Burkitt lymphomaD002051—C83.77158—129
Immunoglobulin light-chain amyloidosisD000075363——11132——22
Precursor t-cell lymphoblastic leukemia-lymphomaD054218——6125——19
AmyloidosisD000686EFO_1001875E857121—117
Large b-cell lymphoma diffuseD016403—C83.3791—116
Hodgkin diseaseD006689—C81452—112
Covid-19D000086382—U07.1336—112
B-cell lymphomaD016393——571——11
Myeloid leukemia acuteD015470—C92.0542—110
Show 104 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Mantle-cell lymphomaD020522—C83.1412——115
Waldenstrom macroglobulinemiaD008258—C88.0210———11
B-cell lymphoma marginal zoneD018442—C88.427——19
PlasmacytomaD010954—C90.325——18
Hematologic neoplasmsD019337——45———8
Blast crisisD001752——25——17
AdenocarcinomaD000230——34——16
B-cell chronic lymphocytic leukemiaD015451—C91.114——15
T-cell lymphoma cutaneousD016410—C84.A22——15
Myeloid leukemiaD007951—C9244———5
Show 88 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———6———17
PruritusD011537—L292———24
GlioblastomaD005909EFO_0000515—3———14
Hairy cell leukemiaD007943—C91.42———13
Vascular diseasesD014652EFO_0004264I771———23
Endometrioid carcinomaD018269——1———12
Sickle cell anemiaD000755EFO_0000697D571———12
Cesarean sectionD002585——1———12
Sleep deprivationD012892—F51.122————2
OligodendrogliomaD009837EFO_0000631—2————2
Show 54 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SarcomaD012509——————22
Myeloproliferative disordersD009196—D47.1————22
Deglutition disordersD003680—R13.1————22
ObesityD009765EFO_0001073E66.9————22
Thyroid diseasesD013959—E00-E07————22
Dental pulp necrosisD003790—K04.1————22
SinusitisD012852EFO_0007486J32————22
RhinosinusitisD000096825——————22
Digestive system neoplasmsD004067——————11
Brenner tumorD001948——————11
Show 62 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameCalcium dobesilate
INNcalcium dobesilate
Description
Calcium dobesilate is a vasoprotective. It is the calcium salt of dobesilic acid. It is a synthetic molecule with the ability to reduce capillary permeability in the body. In Switzerland the drug is sold by the pharmaceutical company OM Pharma under the trade name of Doxium in capsules containing 500 mg of active ingredient.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
O=S(=O)([O-])c1cc(O)ccc1O.O=S(=O)([O-])c1cc(O)ccc1O.[Ca+2]
Identifiers
PDB—
CAS-ID117552-78-0
RxCUI—
ChEMBL IDCHEMBL2106191
ChEBI ID—
PubChem CID29963
DrugBankDBSALT002519
UNII ID5921X1560Q (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 1,542 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
78 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use